| Page 1541 | Kisaco Research
 

Dr. Philippe Steenhout

Medical Director
Gnubiotics

Dr. Philippe Steenhout

Medical Director
Gnubiotics

Dr. Philippe Steenhout

Medical Director
Gnubiotics

Pet Health and the Microbiome: Mother Nature knows best!

This panel will explore current missing essential components in petfood and key learnings from the human milk oligosaccharide (HMO) breakthrough innovation in human infant and adult nutrition. The panel will highlight the need for natural, intelligent, scientifically proven microbiome solutions, tailored specifically for companion animals. This the HMO to AMO (animal milk oligosaccharide) story, exploring nature’s solution for parents and now pet parents.

 

Prof. Kelly Swanson

Professor in Human Nutrition
University of Illinois

Prof. Kelly Swanson

Professor in Human Nutrition
University of Illinois

Prof. Kelly Swanson

Professor in Human Nutrition
University of Illinois
 

Dr David Pride

Associate Director of Microbiology
UC San Diego

Dr David Pride

Associate Director of Microbiology
UC San Diego

Dr David Pride

Associate Director of Microbiology
UC San Diego

Pet health and the Microbiome: Mother Nature knows best!

This panel will explore current missing essential components in petfood and key learnings from the human milk oligosaccharide (HMO) breakthrough innovation in human infant and adult nutrition. The panel will highlight the need for natural, intelligent, scientifically proven microbiome solutions, tailored specifically for companion animals. This the HMO to AMO (animal milk oligosaccharide) story, exploring nature’s solution for parents and now pet parents.

 

Dr Dave Ousterout

CSO & Co-Founder
Locus Bisociences

Dave Ousterout is a co-founder and Chief Scientific Officer for Locus Biosciences. Dave holds a PhD from Duke University where he developed novel gene editing approaches for correcting mutations that cause Duchenne muscular dystrophy. His expertise is in protein engineering and early stage applications of new technologies to treat human diseases. At Locus, Dave is responsible for development of Locus’s crPhage platform and early stage product development. Prior to Locus, Dave was a consultant at McKinsey & Company.

Dr Dave Ousterout

CSO & Co-Founder
Locus Bisociences

Dr Dave Ousterout

CSO & Co-Founder
Locus Bisociences

Dave Ousterout is a co-founder and Chief Scientific Officer for Locus Biosciences. Dave holds a PhD from Duke University where he developed novel gene editing approaches for correcting mutations that cause Duchenne muscular dystrophy. His expertise is in protein engineering and early stage applications of new technologies to treat human diseases. At Locus, Dave is responsible for development of Locus’s crPhage platform and early stage product development. Prior to Locus, Dave was a consultant at McKinsey & Company.

 

Dr Rashid Chotani

Medical Director
IEM

Dr Rashid Chotani

Medical Director
IEM

Dr Rashid Chotani

Medical Director
IEM
 

Dr Erin Duffy

Chief of Research & Development
CARB-X

Dr Erin Duffy

Chief of Research & Development
CARB-X

Dr Erin Duffy

Chief of Research & Development
CARB-X
 

Dr Jon Iredell

Director Centre for Infectious Diseases & Microbiology
Westmead Institute for Medical Research

Dr Jon Iredell

Director Centre for Infectious Diseases & Microbiology
Westmead Institute for Medical Research

Dr Jon Iredell

Director Centre for Infectious Diseases & Microbiology
Westmead Institute for Medical Research
 

Dr Paul Turner

Rachel Carson Professor of Ecology & Evolutionary Biology
Yale University

Dr Paul Turner

Rachel Carson Professor of Ecology & Evolutionary Biology
Yale University

Dr Paul Turner

Rachel Carson Professor of Ecology & Evolutionary Biology
Yale University